A study claims that the quality of AI-generated responses to patient eye care questions is comparable to that of certified ophthalmologists.
Vistagen’s positive PhIII for social anxiety nasal spray pushes stock price up 1,000+%
San Francisco-based Vistagen saw its stock soar more than 1,000% at one point on Monday after unveiling positive topline results from a Phase III trial